September 16, 2024
Quarterly Advocacy Newsletter – Q3 2024
Welcome to Friends’ third Quarterly Advocacy Newsletter of 2024. In Q3, Friends published several peer-reviewed manuscripts with insights on enhancing representation in clinical trials, use of RWD to assess response to treatment, and opportunities for pragmatic elements to be incorporated in clinical trials supporting regulatory decisions. We’re excited to share details on these publications and…
Read More